Reprogrammable microbial cell-based therapeutics against antibiotic-resistant bacteria
- 1 July 2016
- journal article
- review article
- Published by Elsevier in Drug Resistance Updates
- Vol. 27, 59-71
Abstract
No abstract availableKeywords
Funding Information
- National Medical Research Council of Singapore (CBRG11nov109)
- Synthetic Biology Initiative of the National University of Singapore (DPRT/943/09/14)
- Asian Office of Aerospace Research and Development of U.S. Air Force (FA2386-12-1-4055)
- U.S. Defense Threat Reduction Agency (HDTRA1-13-0037)
This publication has 95 references indexed in Scilit:
- Fragments of the Bacterial Toxin Microcin B17 as Gyrase PoisonsPLOS ONE, 2013
- Autonomous bacterial localization and gene expression based on nearby cell receptor densityMolecular Systems Biology, 2013
- Recombinant human DNase I decreases biofilm and increases antimicrobial susceptibility in staphylococciThe Journal of Antibiotics, 2011
- Engineering microbes to sense and eradicate Pseudomonas aeruginosa, a human pathogenMolecular Systems Biology, 2011
- Engineered bacterial communication prevents Vibrio cholerae virulence in an infant mouse modelProceedings of the National Academy of Sciences, 2010
- Administration of a probiotic associated with nasal vaccination with inactivated Lactococcus lactis-PppA induces effective protection against pneumoccocal infection in young miceClinical and Experimental Immunology, 2009
- Hospital and Societal Costs of Antimicrobial‐Resistant Infections in a Chicago Teaching Hospital: Implications for Antibiotic StewardshipClinical Infectious Diseases, 2009
- Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapyProceedings of the National Academy of Sciences, 2009
- The Human Microbiome ProjectNature, 2007
- Dispersing biofilms with engineered enzymatic bacteriophageProceedings of the National Academy of Sciences, 2007